Zevra Therapeutics, Inc. Finance Lease, Right-of-Use Asset, Amortization
Zevra Therapeutics, Inc. (ZVRA) reported Finance Lease, Right-of-Use Asset, Amortization of $1.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2025-11-05
- Zevra Therapeutics, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $1.00K, a 91.67% decline year-over-year.
- Zevra Therapeutics, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-06-30 was $2.00K, a 83.33% decline year-over-year.
- Zevra Therapeutics, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-03-31 was $1.00K, a 91.67% decline year-over-year.
- Zevra Therapeutics, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2024-12-31 was $8.00K, a 33.33% decline year-over-year.
- Zevra Therapeutics, Inc. finance lease, right-of-use asset, amortization for fiscal 2024 was $44.00K, a 56.86% decline from fiscal 2023.
- Zevra Therapeutics, Inc. finance lease, right-of-use asset, amortization for fiscal 2023 was $102.00K, a 20.93% decline from fiscal 2022.
- Zevra Therapeutics, Inc. finance lease, right-of-use asset, amortization for fiscal 2022 was $129.00K, a 0.00% change from fiscal 2021.
- Zevra Therapeutics, Inc. finance lease, right-of-use asset, amortization for fiscal 2021 was $129.00K, a 4.03% increase from fiscal 2020.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2025-09-30 | $1.00K 10-Q · filed 2025-11-05 | $3.00K derived: sum of 2 quarters · filed 2025-11-05 | $4.00K 10-Q · filed 2025-11-05 | $12.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2025-06-30 | $2.00K 10-Q · filed 2025-08-12 | $3.00K 10-Q · filed 2025-08-12 | $11.00K derived: sum of 3 quarters · filed 2025-08-12 | $23.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2025-03-31 | $1.00K 10-Q · filed 2025-05-13 | $9.00K derived: sum of 2 quarters · filed 2025-05-13 | $21.00K derived: sum of 3 quarters · filed 2025-11-05 | $33.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $20.00K derived: sum of 2 quarters · filed 2025-11-05 | $32.00K derived: sum of 3 quarters · filed 2025-11-05 | $44.00K 10-K · filed 2025-03-12 |
| 2024-09-30 | $12.00K 10-Q · filed 2025-11-05 | $24.00K derived: sum of 2 quarters · filed 2025-11-05 | $36.00K 10-Q · filed 2025-11-05 | $48.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $12.00K 10-Q · filed 2025-08-12 | $24.00K 10-Q · filed 2025-08-12 | $36.00K derived: sum of 3 quarters · filed 2025-08-12 | $62.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $12.00K 10-Q · filed 2025-05-13 | $24.00K derived: sum of 2 quarters · filed 2025-05-13 | $50.00K derived: sum of 3 quarters · filed 2025-05-13 | $82.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $38.00K derived: sum of 2 quarters · filed 2025-03-12 | $70.00K derived: sum of 3 quarters · filed 2025-03-12 | $102.00K 10-K · filed 2025-03-12 |
| 2023-09-30 | $26.00K 10-Q · filed 2024-11-13 | $58.00K derived: sum of 2 quarters · filed 2024-11-13 | $90.00K 10-Q · filed 2024-11-13 | $123.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $32.00K 10-Q · filed 2024-08-14 | $64.00K 10-Q · filed 2024-08-14 | $97.00K derived: sum of 3 quarters · filed 2024-08-14 | $129.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $32.00K 10-Q · filed 2024-05-09 | $65.00K derived: sum of 2 quarters · filed 2024-05-09 | $97.00K derived: sum of 3 quarters · filed 2024-05-09 | $129.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $65.00K derived: sum of 2 quarters · filed 2024-04-01 | $97.00K derived: sum of 3 quarters · filed 2024-04-01 | $129.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $32.00K 10-Q · filed 2023-11-07 | $64.00K derived: sum of 2 quarters · filed 2023-11-07 | $96.00K 10-Q · filed 2023-11-07 | $129.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $32.00K 10-Q · filed 2023-08-14 | $64.00K 10-Q · filed 2023-08-14 | $97.00K derived: sum of 3 quarters · filed 2023-08-14 | $129.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $32.00K 10-Q · filed 2023-05-15 | $65.00K derived: sum of 2 quarters · filed 2023-05-15 | $97.00K derived: sum of 3 quarters · filed 2023-05-15 | $129.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $65.00K derived: sum of 2 quarters · filed 2023-03-07 | $97.00K derived: sum of 3 quarters · filed 2023-03-07 | $129.00K 10-K · filed 2023-03-07 |
| 2021-09-30 | $32.00K 10-Q · filed 2022-11-10 | $64.00K derived: sum of 2 quarters · filed 2022-11-10 | $96.00K 10-Q · filed 2022-11-10 | $128.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $32.00K 10-Q · filed 2022-08-12 | $64.00K 10-Q · filed 2022-08-12 | $96.00K derived: sum of 3 quarters · filed 2022-08-12 | $127.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $32.00K 10-Q · filed 2022-05-12 | $64.00K derived: sum of 2 quarters · filed 2022-05-12 | $95.00K derived: sum of 3 quarters · filed 2022-05-12 | $125.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $63.00K derived: sum of 2 quarters · filed 2022-03-31 | $93.00K derived: sum of 3 quarters · filed 2022-03-31 | $124.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $31.00K 10-Q · filed 2021-11-10 | $61.00K derived: sum of 2 quarters · filed 2021-11-10 | $92.00K 10-Q · filed 2021-11-10 | $123.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $30.00K 10-Q · filed 2021-08-13 | $61.00K 10-Q · filed 2021-08-13 | $92.00K derived: sum of 3 quarters · filed 2021-08-13 | $123.00K derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | $31.00K 10-Q · filed 2021-05-14 | $62.00K derived: sum of 2 quarters · filed 2021-05-14 | $93.00K derived: sum of 3 quarters · filed 2021-05-14 | $123.00K derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $62.00K derived: sum of 2 quarters · filed 2021-03-12 | $92.00K derived: sum of 3 quarters · filed 2021-03-12 | $123.00K 10-K · filed 2021-03-12 |
| 2019-09-30 | $31.00K 10-Q · filed 2020-10-30 | $61.00K derived: sum of 2 quarters · filed 2020-10-30 | $92.00K 10-Q · filed 2020-10-30 | |
| 2019-06-30 | $30.00K 10-Q · filed 2020-08-12 | $61.00K 10-Q · filed 2020-08-12 | ||
| 2019-03-31 | $31.00K 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |